Nerac

Information That Drives Innovation

We’re here to help with your research needs
+1 860 872 7000
Customer Access
  • Home
  • What We Do
    • Nerac IPDex™
    • Innovation Insights and Consulting Practice
    • Regulatory
    • Medical Device and Life Sciences
    • Technology Scouting and Innovation
    • Market Research
    • Intellectual Property
    • Commercialization Services for TTOs and Start-Ups
    • Critical Updates
  • Who We Serve
  • How to Engage
  • Why Nerac?
  • Meet our Team
    • Leadership Team
    • Our Analysts
    • Our Partners
  • Nerac Insights and Publications
    • Articles
    • Case Studies
    • Press Room
    • Videos
    • Webcasts
    • White Papers
  • Contact Us
You are here: Home / Nerac Insights / Articles / Nutraceutical IP and Regulatory Claims

Nutraceutical IP and Regulatory Claims

Facebook0
Google+0
LinkedIn0
Twitter0

Originally published September, 2008

Food makers increasingly rely on patented technologies to improve functionality, but strict regulations hamper marketing benefits.

The United States functional foods market is relatively immature compared to that of nutraceuticals. From an intellectual property standpoint, this may be because functional food technology develops from within the food industry, while nutraceuticals may come as the result of convergence between the food industry and industries with greater IP acumen.

Historically, food technology is not an area of frequent patenting relative to other technologies such as formulation science that impacts the nutraceutical and functional food markets. While patenting of food technologies has risen in recent years, most of the filings are classified more like medicines and usually cover processes such as extraction or purification rather than bare end product—and that results in the FDA treating the products as drugs. Interestingly, the FDA regulates nutraceuticals less stringently than foods in terms of what health claims can be made.

Want to read the rest of the article? Fill out the form to download: Nutraceutical IP and Regulatory Claims
Get Download Link

 

Related Posts

  • Bringing Functional Foods to Market: FDA’s Regulatory Mandate Drives the Process
    47
    Originally published February, 2011 Introduction Bringing a new functional food product to market is a potentially complex process with many decision points driven by the US Food and Drug Administration’s (FDA) regulatory mandate. There is no single definition for functional foods, also known as nutraceuticals. They may encompass a range of products and uses, including…
    Tags: food, fda, functional, foods, read, claims, published, originally
  • 3D Printing: Legal Landscape and Future Challenges
    43
    Originally published January, 2014 Although the future promise of 3D printing, also referred to as additive manufacturing (AM), has been recently promoted for its promise of reduced costs and production times, as well as an increased complexity of integral components, the legal framework is far from clear. It is useful to analyze the challenges of…
    Tags: read, published, originally, ip, patenting
  • Technology Transfer Problems and Perspectives: An Examination of Recent Literature
    41
    By Nerac IP Analysts The major idea behind the Bayh-Dole act passed in 1980 was to move control of technology discovered under federal grant funding from the federal government itself to universities.  The goal was to speed development of new technology from university labs to the marketplace.  How that was to be done was not…
    Tags: technology, ip
  • Case Studies
  • White Papers
  • Webcasts
  • Articles
    • Nerac Strategist
    • Energy
    • Food & Nutrition
    • Intellectual Property
    • Regulatory
    • Technology & Innovation
    • Medical Device & Healthcare
    • Pharmaceutical
    • Engineering
    • Market Research
    • Critical Alerts
    • Chemistry/Advanced Materials
  • Press Room

Click here to learn more about….

3d printing advanced materials aerospace Ask Kevin Videos biotech CFDA clinical literature evaluations commercialization strategies competitive intelligence conflict minerals Disruptive Technologies energy EU MDR FDA food helga weires Industry 4.0 innovation Inspiring Next intellectual property IP market analysis market research medical device medical devices nerac Nerac client questions Nerac Strategist notified body audit open innovation patenting patenting strategies patent landscape pharmaceutical Post-Market Surveillance R&D regulatory regulatory compliance Robert Beinstein Rosemarie Szostak specialty chemicals Sustainable Development Goals technology scouting Tech Scouting XcellR8
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • YouTube
  • Career Opportunities
  • Privacy Policy

Copyright © 2023 Nerac · One Technology Drive · Tolland, CT 06084 · 1.860.872.7000

Sign Up for the Nerac Strategist

Like what you see? Sign up here to receive the Nerac Strategist newsletter, a compilation of analyst insights on rapidly developing industry issues, compliance challenges and commercial opportunities!

  • This field is for validation purposes and should be left unchanged.